Vaxart, Inc.
(NASDAQ : VXRT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.09%178.001.3%$463.16m
CELGCelgene Corporation
0.83%97.321.3%$421.63m
GILDGilead Sciences, Inc.
1.28%67.210.9%$393.48m
BIIBBiogen Inc.
2.14%232.551.3%$354.98m
ILMNIllumina, Inc.
1.38%348.733.5%$271.63m
REGNRegeneron Pharmaceuticals, Inc.
2.19%311.932.6%$234.00m
AAgilent Technologies, Inc.
0.40%70.251.6%$212.92m
VRTXVertex Pharmaceuticals Incorporated
2.17%173.921.9%$198.41m
ARRYArray BioPharma Inc.
56.95%46.448.2%$186.05m
EXASExact Sciences Corporation
0.56%110.3925.3%$183.89m
ALXNAlexion Pharmaceuticals, Inc.
2.43%120.802.0%$176.35m
BMRNBioMarin Pharmaceutical Inc.
3.97%84.054.3%$136.00m
MRTXMirati Therapeutics Inc.
6.34%100.242.5%$113.81m
IONSIonis Pharmaceuticals, Inc.
3.99%64.578.2%$96.81m
INCYIncyte Corporation
4.97%81.572.5%$91.64m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.